本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ibere Pharmaceuticals

10.18
0.0000
成交量:- -
成交额:- -
市值:1.76亿
市盈率:28.40
高:10.18
开:10.18
低:10.18
收:10.18
52周最高:10.75
52周最低:9.71
股本:1,725.00万
流通股本:1,246.99万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):0.3584
每股收益(LYR):0.1050
净资产收益率:--
总资产收益率:-0.90%
市净率:-30.10
市盈率(LYR):96.92

数据加载中...

2023/03/02

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/02/15

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/09/27

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/16

重要事件披露

8-K/A [Amend] - Current report
2021/08/16

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/13

重要事件披露

8-K - Current report